Oyster Point Pharma’s Nasal Spray Drug gets US FDA Approval to Treat Dry Eye Disease
The company ‘Oyster Point Pharma Inc.’ said, the US FDA has now approved the Tyrvaya varenicline solution nasal spray 0.03 mg for the treatment of the symptoms and signs of the dry eye disease, and the company also said, the Tyrvaya nasal spray has been the first and only nasal spray, that has been approved […]
Continue Reading